ANNX vs REGN: Which Stock is Better?

Side-by-side comparison of Annexon Inc and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

ANNX

Annexon Inc

$6.54

REGN

Regeneron Pharmaceuticals Inc

$750.57

Key Metrics Comparison

MetricANNXREGNWinner
Market Cap$1.05B$79.35BREGN
P/E RatioN/A18.08REGN
EPS (TTM)$N/A$41.51REGN
Revenue Growth0.0%0.0%REGN
Gross Margin0.0%44.6%REGN

Analyze ANNX

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ANNX or REGN a better investment?

Comparing ANNX and REGN: Annexon Inc has a market cap of $1.05B while Regeneron Pharmaceuticals Inc has $79.35B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ANNX and REGN?

ANNX (Annexon Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ANNX or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: ANNX or REGN?

REGN has higher revenue growth at 0.0% vs 0.0% for ANNX.

Which company is more profitable: ANNX or REGN?

Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to 0.0% for ANNX.

Which is the larger company: ANNX or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $79.35B compared to $1.05B for ANNX.

Should I buy ANNX or REGN in 2026?

Both ANNX and REGN have investment merit. ANNX trades at $6.54 while REGN trades at $750.57. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ANNX and REGN stock?

Key differences: Market Cap ($1.05B vs $79.35B), P/E Ratio (N/A vs 18.1x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 44.6%).

Popular Stock Comparisons